28 Development of a systematic approach to reduce the likelihood of patient harm associated with anticoagulant therapy
PurposeCoumadin identified by Institute for Safe Medication Practice as high–risk medication with narrow therapeutic window and high risk of life threatening adverse effectsAnticoagulants identified as one of the top five drug types associated with patient safety incidentsMaintaining INR in recommen...
Gespeichert in:
Veröffentlicht in: | Heart (British Cardiac Society) 2018-02, Vol.104 (Suppl 2), p.A10 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!